Upsher-Smith Launches Haloperidol Tablets, USP

Upsher-Smith Laboratories, LLC (Upsher-Smith) has announced the launch of haloperidol tablets, USP in 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg and 20 mg strengths. Haloperidol tablets are a generic version of the brand product, Haldol Tablets. The haloperidol tablet market had US sales of approximately $41 million for the 12 months ending August 2019, according to IQVIA.

Reference

Uspher-Smith launches haloperidol tablets, USP. PR Newswire website. Published January 13, 2020. https://www.prnewswire.com/news-releases/upsher-smith-launches-haloperidol-tablets-usp-300985540.html. Accessed January 14, 2020.